Abstract
Dysregulated catecholamine signaling has long been implicated in drug abuse. Although much is known about adaptations following chronic drug administration, little work has investigated how a single drug exposure paired with withdrawal influences catecholamine signaling in vivo. We used fast-scan cyclic voltammetry in freely moving rats to measure real-time catecholamine overflow during acute morphine exposure and naloxone-precipitated withdrawal in two regions associated with the addiction cycle: the dopamine-dense nucleus accumbens (NAc) and norepinephrine-rich ventral bed nucleus of the stria terminalis (vBNST). We compared dopamine transients in the NAc with norepinephrine concentration changes in the vBNST, and correlated release with specific withdrawal-related behaviors. Morphine increased dopamine transients in the NAc, but did not elicit norepinephrine responses in the vBNST. Conversely, dopamine output was decreased during withdrawal, while norepinephrine was released in the vBNST during specific withdrawal symptoms. Both norepinephrine and withdrawal symptoms could be elicited in the absence of morphine by administering naloxone with an α2 antagonist. The data support reciprocal roles for dopamine and norepinephrine signaling during drug exposure and withdrawal. The data also support the allostasis model and show that negative-reinforcement may begin working after a single exposure/withdrawal episode.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aston-Jones G, Delfs JM, Druhan J, Zhu YAN (1999). The bed nucleus of the stria terminalis: a target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 877: 486–498.
Berke JD, Hyman SE (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515–532.
Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ et al (2007). Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27: 791–795.
Covey DP, Roitman MF, Garris PA (2014). Illicit dopamine transients: reconciling actions of abused drugs. Trends Neurosci 37: 200–210.
Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, Ragozzino ME et al (2013). Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J Neurosci 33: 452–463.
Davis WM, Smith SG, Khalsa JH (1975). Noradrenergic role in the self-administration of morphine or amphetamine. Pharmacol Biochem Behav 3: 477–484.
Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430–434.
Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS (1998). Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806: 127–140.
Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274–5278.
Dumont EC, Williams JT (2004). Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198–8204.
Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD et al (2004). Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30: 657–668.
Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000). Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23: 138–150.
Everitt BJ, Robbins TW (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481–1489.
Forray MI, Gysling K (2004). Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res Brain Res Rev 47: 145–160.
Fox ME, Studebaker RI, Swofford NJ, Wightman RM (2015). Stress and drug dependence differentially modulate norepinephrine signaling in animals with varied HPA axis function. Neuropsychopharm 40: 1752–1761.
Fuentealba JA, Forray MI, Gysling K (2000). Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis. J Neurochem 75: 741–748.
Georges F, Aston-Jones G (2002). Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22: 5173–5187.
Harris GC, Aston-Jones G (1994). Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371: 155–157.
Hemby SE, Martin TJ, Co C, Dworkin SI, Smith JE (1995). The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exp Ther 273: 591–598.
Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Ann Rev Neurosci 29: 565–598.
Juarez B, Han M-H (2016). Diversity of dopaminergic neural circuits in response to drug exposure. Neuropsychopharm (doi:10.1038/npp.2016.32; e-pub ahead of print).
Kaufling J, Aston-Jones G (2015). Persistent adaptations in afferents to ventral tegmental dopamine neurons after opiate withdrawal. J Neurosci 35: 10290–10303.
Kessler JP, Jean A (1985). Identification of the medullary swallowing regions in the rat. Exp Brain Res 57: 256–263.
Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharm 35: 217–238.
Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA et al (2015). Clonidine maintenance prolongs opioid abstinence and decouples stress from craving in daily life: a randomized controlled trial with ecological momentary assessment. Am J Psychiatry 172: 760–767.
Leri F, Flores J, Rodaros D, Stewart J (2002). Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713–5718.
Mazei-Robison MS, Nestler EJ (2012). Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med 2: a012070.
McElligott ZA, Fox ME, Walsh PL, Urban DJ, Ferrel MS, Roth BL et al (2013). Noradrenergic synaptic function in the bed nucleus of the stria terminalis varies in animal models of anxiety and addiction. Neuropsychopharmacology 38: 1665–1673.
Mitrano DA, Schroeder JP, Smith Y, Cortright JJ, Bubula N, Vezina P et al (2012). Alpha-1 adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 37: 2161–2172.
Navarro-Zaragoza J, Laorden ML, Milanes MV (2014). Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR). Toxicology 326: 36–43.
Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119–128.
Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD (2006). Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science 311: 1017–1020.
Park J, Bucher ES, Budygin EA, Wightman RM (2015). Norepinephrine and dopamine transmission in 2 limbic regions differentially respond to acute noxious stimulation. Pain 156: 318–327.
Park J, Bucher ES, Fontillas K, Owesson-White C, Ariansen JL, Carelli RM et al (2013). Opposing catecholamine changes in the bed nucleus of the stria terminalis during intracranial self-stimulation and its extinction. Biol Psychiatry 74: 69–76.
Park J, Wheeler RA, Fontillas K, Keithley RB, Carelli RM, Wightman RM (2012). Catecholamines in the bed nucleus of the stria terminalis reciprocally respond to reward and aversion. Biol Psychiatry 71: 327–334.
Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM (2003). Subsecond dopamine release promotes cocaine seeking. Nature 422: 614–618.
Pothos E, Rada P, Mark GP, Hoebel BG (1991). Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res 566: 348–350.
Ramesh D, Gamage TF, Vanuytsel T, Owens RA, Abdullah RA, Niphakis MJ et al (2013). Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. Neuropsychopharmacology 38: 1039–1049.
Rodeberg NT, Johnson JA, Cameron CM, Saddoris MP, Carelli RM, Wightman RM (2015). Construction of training sets for valid calibration of in vivo cyclic voltammetric data by principal component analysis. Anal Chem 87: 11484–11491.
Roitman MF, Wheeler RA, Wightman RM, Carelli RM (2008). Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat Neurosci 11: 1376–1377.
Schulteis G, Heyser CJ, Koob GF (1999). Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. Behav Pharmacol 10: 235–242.
Shaham Y, Highfield D, Delfs J, Leung S, Stewart J (2000). Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12: 292–302.
Sombers LA, Beyene M, Carelli RM, Wightman RM (2009). Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci 29: 1735–1742.
Sustkova-Fiserova M, Jerabek P, Havlickova T, Kacer P, Krsiak M (2014). Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats. Psychopharmacology (Berl) 231: 2899–2908.
Twining RC, Wheeler DS, Ebben AL, Jacobsen AJ, Robble MA, Mantsch JR et al (2015). Aversive stimuli drive drug seeking in a state of low dopamine tone. Biol Psychiatry 77: 895–902.
Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A (2003). Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39: 401–407.
Vander Weele CM, Porter-Stransky KA, Mabrouk OS, Lovic V, Singer BF, Kennedy RT et al (2014). Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery. Eur J Neurosci 40: 3041–3054.
Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007). Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64: 1575–1579.
Vranjkovic O, Gasser PJ, Gerndt CH, Baker DA, Mantsch JR (2014). Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J Neurosci 34: 12504–12514.
Wang X, Cen X, Lu L (2001). Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432: 153–161.
Weinshenker D, Schroeder JP (2007). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32: 1433–1451.
Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE (1996). Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16: 3474–3485.
Acknowledgements
MEF designed the study, collected, and analyzed voltammetric data. NTR assisted with collection and analysis of dopamine transients. MEF wrote the paper and prepared the figures with contributions from NTR and RMW. We thank Dr Elyse Dankoski for comments on an early version of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Rights and permissions
About this article
Cite this article
Fox, M., Rodeberg, N. & Wightman, R. Reciprocal Catecholamine Changes during Opiate Exposure and Withdrawal. Neuropsychopharmacol 42, 671–681 (2017). https://doi.org/10.1038/npp.2016.135
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2016.135
This article is cited by
-
Opioid withdrawal: role in addiction and neural mechanisms
Psychopharmacology (2023)
-
Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine
Scientific Reports (2020)
